Incremental dementia-related expenditures in a medicaid population

American Journal of Geriatric Psychiatry

Volumn 20, Issue 1, 2012, Pages 73-83

  Bharmal, Murtuza F ^a,b   Dedhiya, Seema ^a,b   Craig, Bruce A ^b,c   Weiner, Michael ^d,e,f   Rosenman, Marc ^d,f   Sands, Laura P ^b,g   Modi, Ankita ^a,b   Doebbeling, Caroline ^h   Thomas III, Joseph ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INDIANA UNIVERSITY CENTER FOR AGING RESEARCH   (United States)

^f REGENSTRIEF INSTITUTE   (United States)

^g PURDUE UNIVERSITY   (United States)

^h Federal Highway Administration   (United States)

Author keywords

Cost of treatment; dementia; expenditures; Medicaid; nursing home; utilization

Indexed keywords

ARTICLE; COST OF ILLNESS; DEMENTIA; DRUG COST; HEALTH CARE COST; HOSPITAL COST; HUMAN; MEDICAID; NURSING HOME; PREVALENCE; RETROSPECTIVE STUDY;

EID: 84155167504     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318209dce4     Document Type: Article

References (35)

1. Brodaty H and Lie d: Symptomatology: Functional Capacity and Behavior, in Health Economics of Dementia. New York, John-Wiley, 1998:31-51
2. Bharucha AJ, Pandav R, Shen C, et al: Predictors of nursing facility admission: a 12-year epidemiology study in the United States. J Am Geriatr Soc 2004; 52:434-439
3. Magaziner J, German P, Zimmerman SI, et al: The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: diagnosis by expert panel. Gerontologist 2000; 40:663-672
4. Catlin A, Cowan C, Hartman M, et al: National health spending in 2006: a year of change for prescription drugs. Health Aff (Millwood). 2008; 27:14-29
5. Martin BC, Ricci JF, Kotzan JA, et al: The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord 2000; 14: 151-159
6. Menzin J, Lang K, Friedman M, et al: The economic cost Alzheimer's disease and related dementias to the California Medi-caid Program in 1995. Am J Geriatric Psychiatry 1999; 7:300-308
7. Bharmal MF, Weiner M, Sands LP, et al: Impact of patient selection criteria on prevalence estimates and prevalence of diagnosed dementia in a Medicaid population. Alzheimer Dis Assoc Disord 2007; 21:92-100
8. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40:373-382
9. Romano PS, Roos LL, Jollis JG: Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993; 46:1075-1079
10. Diehr P, Yanez D, Ash A, et al: Methods for analyzing health care utilization and costs. Annu Rev Public Health 1999; 20:125-144
11. Barber J, Thompson S: Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 2004; 9: 197-204
12. Buntin MB, Zaslavsky AM: Too much ado about two-part models and transformation? Comparing methods of modeling medicare expenditures. J Health Econ 2004; 23(3):525-542
13. Zhou X, Melfi CA, Hui SL: Methods for comparison of cost data. Ann Intern Med 1997; 127:752-756
14. Duan N: Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1983; 78:605-610
15. Mullahy J: Much ado about two: reconsidering transformation and the two-part model in health econometrics. J Health Econ 1998; 17: 247-281
16. Park R: Estimation with heteroscedastic error terms. Economet-rica 1966; 34:888
17. Cameron AC, Trivedi PK: Econometric models based on count data: comparisons and applications of some estimators and tests. J Appl Econ 1986; 1:29-53
18. Bao Y: Predicting the use of outpatient mental health services: do modeling approaches make a difference? Inquiry 2002; 39(2):168-183
19. Greene WH: Accounting for excess zeros and sample selection in Poisson and negative binomial regression models. Working paper, Stern School of Business, NYU EC-94-10, 1994
20. Long JS: Regression models for categorical and limited dependent variables. Thousand Oaks, CA: Sage, 1997
21. Vuong QH: Likelihood ratio tests for model selection and nonnested hypotheses. Econometrica 1989; 57:307-333
22. D'Agostino R, Stephens M: Goodness-of-Fit Techniques. New York, Marcel Dekker, 1986
23. Glejser H: A new test for heteroscedasticity. J Am Statist Assoc 1969; 64:316-323
24. SAS Institute, Inc. SAS/STAT Guide for Personal Computers, Version 8.02. Cary, NC, SAS Institute Inc., 2001
25. StataCorp. Stata Statistical Software Release 8.0. Stata Corporation: College Station, TX, 2004
26. Hill JW, Futterman R, Duttagupta S, et al: Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology 2002; 58:62-70
27. Leibson C, Owens T, O'Brien P, et al: Use of physician and acute care services by persons with and without Alzheimer's disease: a population-based comparison. J Am Geriatr Soc 1999; 47(7): 864-869
28. Gutterman EM, Markowitz JS, Lewis B, et al: Cost of Alzheimer's disease and related dementia in managed-Medicare. J Am Geriatr Soc 1999; 47:1065-1071
29. Plosker GL, Lyseng-Williamson KA: Memantine: a pharmacoeco-nomic review of its use in moderate-to-severe Alzheimer's disease. Pharmacoeconomics 2005; 23:193-206
30. Sano M: Economic effect of cholinesterase inhibitor therapy: implications for managed care. Manag Care Interface 2004; 17:44-49
31. Stefanacci RG, Cafiero AC: Antidementia agents: what is important in this class. Manag Care 2005; 14(suppl 5):11-16
32. Sands LP, Xu H, Weiner M, et al: Comparison of resource utilization for Medicaid dementia patients using nursing homes versus home and community based waivers for long-term care. Med Care 2008; 46(4):449-453
33. Douglas S, James I, Ballard C: Non-pharmacological interventions in dementia. Adv Psychiatr Treat 2004; 10:171-179
34. Robinson L, Hutchings D, Corner L, et al: A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. Health Technol Assess 2006;10(26):i-ix, 1-124
35. Hulme C, Wright J, Crocker T, et al: Non-pharmacological approaches for dementia that informal carers might try or access: a systematic review. Int J Geriatr Psychiatry 2010; 25(7): 756-763